Algen Healthcare Ltd offers high-quality Levodropropizine 30mg + Chlorpheniramine Maleate 2mg/5ml Syrup for third-party manufacturing and PCD pharma franchise. This syrup is ideal for treating dry cough and allergic symptoms.
This syrup is a combination of two medicines:
Levodropropizine: A cough suppressant that controls the cough reflex.
Chlorpheniramine Maleate (CPM): An antihistamine that relieves allergy symptoms like runny nose, sneezing, and irritation.
Together, they provide fast relief from dry and allergic coughs.
We are one of India’s trusted pharma companies, offering:
WHO-GMP certified manufacturing
Fast delivery and low minimum order quantities
Customizable packaging and labeling
Transparent and affordable pricing
Exclusive monopoly rights for PCD franchise partners
Algen Healthcare welcomes pharma professionals to join us as PCD franchise partners for this syrup. Benefits include:
Monopoly-based marketing rights
Free promotional material
High profit margins
Area-wise distribution support
Looking for reliable contract manufacturing? We offer:
Accurate formulations
Attractive and durable packaging
Custom brand name printing
Timely production and delivery
Full quality control and documentation
Composition: Levodropropizine 30mg + Chlorpheniramine Maleate 2mg per 5ml
Form: Syrup
Use: Dry cough and allergic cough relief
Packaging: Customized as per requirement
Storage: Keep in a cool, dry place
Algen Healthcare Ltd
📞 +91 9868265827, +91 9319088494
📧 sales@algenhealthcare.co
📍 Plot No: 456, First Floor, Industrial Area, Phase: 1, Panchkula, Haryana (134113)
🌐 www.algenhealthcare.co
Q1. Is this syrup suitable for children?
Please consult a doctor for pediatric use. Dosage varies with age and condition.
Q2. Can I get this syrup under my brand name?
Yes, we offer full customization with your brand name and packaging.
Q3. What is the MOQ for third-party manufacturing?
Minimum order quantity depends on your packaging requirements. Contact us for details.
Q4. Do you offer monopoly rights for this product?
Yes, we offer area-wise monopoly rights under our PCD pharma franchise model.